Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017

Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (SP) has been used for mass drug-administration pilot programs. In March 2016, nationwide molecular surveillance was initiated to assess molecular resis...

Full description

Bibliographic Details
Main Authors: Eric Rogier, Camelia Herman, Curtis S. Huber, Karen E.S. Hamre, Baby Pierre, Kimberly E. Mace, Jacquelin Présumé, Gina Mondélus, Ithamare Romilus, Tamara Elismé, Thomas P. Eisele, Thomas Druetz, Alexandre Existe, Jacques Boncy, Jean F. Lemoine, Venkatachalam Udhayakumar, Michelle A. Chang
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-05-01
Series:Emerging Infectious Diseases
Subjects:
Plasmodium falciparum
Haiti
drug resistance
chloroquine
sulfadoxine
pyrimethamine
Online Access:https://wwwnc.cdc.gov/eid/article/26/5/19-0556_article

Internet

https://wwwnc.cdc.gov/eid/article/26/5/19-0556_article

Similar Items